Clinical Trials Browser

Cervical Esophagus Adenocarcinoma

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Neoplasm Metastasis

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Anatomic Stage IV Breast Cancer AJCC v8

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Locally Advanced Rectal Cancer

Rectal Neoplasms

Rectal Neoplasms

Breast Neoplasms

Rectal Neoplasms

Neoplasm, Residual, Triple Negative Breast Neoplasms

Colonic Neoplasms

Neoplasm Metastasis, Neoplasms

Nasopharyngeal Carcinoma

Pathologic Complete Response, Rectal Neoplasms

Rectal Neoplasms

Breast Neoplasms, Meningeal Neoplasms

Triple Negative Breast Neoplasms

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Breast Neoplasms

Locally Advanced Rectal Cancer

Nasopharangeal Cancer

Anus Neoplasms

Rectal Neoplasms

Esophageal Neoplasms

Rectal Neoplasms

Breast Neoplasms

Breast Neoplasms

Rectal Neoplasms

Breast Neoplasms

Rectal Neoplasms

Hypopharyngeal Neoplasms

Advanced Colorectal Cancer

Brain Neoplasms, Breast Neoplasms

Colorectal Cancer Metastatic

Biliary Tract Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Breast Neoplasms

Appendiceal Neoplasms, Neoplasm Metastasis

Brain Neoplasms, Breast Neoplasms

Stomach Neoplasms

Neuroendocrine Tumors

Pancreatic Neoplasms

Breast Neoplasms

Meningeal Neoplasms, Meningeal Carcinomatosis

Triple Negative Breast Neoplasms

Breast Neoplasms, Head and Neck Neoplasms, Colorectal Neoplasms

Breast Neoplasms

Clinical Trials

NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

EVOLVE-BDT

LAP100

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

TORCH-iTNT

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer

The Efficacy and Safety of Trastuzumab Rezetecan (SHR-A1811) in HER2-Low Unresectable/Metastatic Breast Cancer Patients With Visceral Crisis

SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

TRIUNITE-08

EMPOWER

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study

TARMAC

CHIMERA

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

SMART TNT

A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma

Adaptive Radiation in Anal Cancer

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

CAPELA

INSIGHT

WW3

Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer

mRCAT-E

The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma

Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer

SOLARA

Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

BRE-08

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling

Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer

CapTemY90

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

ETIC-LM

CAPPA

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer